Droxinostat

CAS No. 99873-43-5

Droxinostat ( NS 41080;NS-41080;NS41080 )

Catalog No. M16918 CAS No. 99873-43-5

Droxinostat (NS-41080) is a selective HDAC inhibitor with IC50 of 16.9, 2.47 and 1.46 uM for HDAC3, HDAC6 and HDAC8, respectively.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 28 In Stock
5MG 41 In Stock
10MG 78 In Stock
25MG 167 In Stock
50MG 250 In Stock
100MG 372 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Droxinostat
  • Note
    Research use only, not for human use.
  • Brief Description
    Droxinostat (NS-41080) is a selective HDAC inhibitor with IC50 of 16.9, 2.47 and 1.46 uM for HDAC3, HDAC6 and HDAC8, respectively.
  • Description
    Droxinostat (NS-41080) is a selective HDAC inhibitor with IC50 of 16.9, 2.47 and 1.46 uM for HDAC3, HDAC6 and HDAC8, respectively; does not inhibit HDAC1, HDAC2, HDAC4, HDAC5, HDAC7, HDAC9, and HDAC10 with IC50 of >20 uM; sensitizes malignant cells to death receptor ligands FAS and TRAIL sensitization with IC50 of 20 and 39 uM, respectively; decreases the expression of the caspase-8 inhibitor FLIP, downregulates c-FLIP(L) and c-FLIP(S) mRNA and protein levels, causes PARP degradation, reduces cell survival, and induces apoptosis in MCF-7 breast cancer cells.
  • Synonyms
    NS 41080;NS-41080;NS41080
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    HDAC
  • Recptor
    HDAC10;HDAC3;HDAC6;HDAC8;HDAC9
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    99873-43-5
  • Formula Weight
    243.70
  • Molecular Formula
    C11H14ClNO3
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    O=C(NO)CCCOC1=CC=C(Cl)C=C1C
  • Chemical Name
    Butanamide, 4-(4-chloro-2-methylphenoxy)-N-hydroxy-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Wood TE, et al. Mol Cancer Ther. 2010 Jan;9(1):246-56.
2. Bijangi-Vishehsaraei K, et al. Mol Cell Biochem. 2010 Sep;342(1-2):133-142.
3. McCourt C, et al. Clin Cancer Res. 2012 Jul 15;18(14):3822-33.
4. Liu J, et al. Transl Oncol. 2016 Feb;9(1):70-78.
molnova catalog
related products
  • Belinostat

    Belinostat is a novel hydroxamic acid-type histone deacetylase (HDAC) inhibitor with antineoplastic activity.

  • ACY-738

    ACY-738 (ACY738) is a potent and specific HDAC6 inhibitor (IC50=1.7 nM) with improved brain bioavailability; displays 60-1500 fold selectivity over class I HDACs.

  • PCI-24781

    A broad spectrum HDAC inhibitor; inhibits pure recombinant HDAC1 with Ki of 7 nM.